Mar 3, 2026
Gilbert Ray Cisneros Jr.- Amount
- $1,001 to $15,000
- Filed
- Apr 7, 2026
Congress ticker disclosure profile
As of August 4 at 9:02 AM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference ITT. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
25
Member filers
9
Disclosed ranges
$303K
Most active member desks
13 sells vs 11 buys
Republican · House · TX-10.0
Republican · House · MI-9.0
Democrat · House · CA-17.0
Democrat · House · CA-31.0
Democrat · House · NJ-5.0
Republican · House · IN-6.0
Democrat · House · MD-6.0
Public filer · House · 22.0
Public filer · House · 3.0
Latest trade Mar 3, 2026
Mar 3, 2026
Gilbert Ray Cisneros Jr.Dec 11, 2025
Gilbert Ray Cisneros Jr.Nov 6, 2025
Gilbert Ray Cisneros Jr.Oct 31, 2025
Lisa C. McClainOct 30, 2025
Lisa C. McClainOct 30, 2025
Lisa C. McClainJun 17, 2025
Lisa McclainMar 31, 2025
Jefferson ShreveMar 5, 2025
April Mcclain DelaneyFeb 24, 2025
Jefferson ShreveOct 31, 2024
Josh GottheimerJun 21, 2024
Josh GottheimerMay 16, 2024
Michael T. McCaulMay 13, 2024
Michael T. McCaulApr 24, 2024
Michael T. McCaulNov 1, 2023
Michael T. McCaulMar 16, 2023
Michael T. McCaulDec 28, 2022
Michael T. McCaulJun 21, 2022
Josh GottheimerMay 23, 2022
Ro KhannaMay 5, 2022
Ro KhannaFeb 11, 2020
Ro KhannaJan 8, 2020
Ro KhannaMay 18, 2016
Richard L. HannaFeb 1, 2016
Thomas Macarthur| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Mar 3, 2026 | Gilbert Ray Cisneros Jr. | Buy | $1,001 to $15,000 | Apr 7, 2026 | Open card |
| Dec 11, 2025 | Gilbert Ray Cisneros Jr. | Buy | $1,001 to $15,000 | Jan 12, 2026 | Open card |
| Nov 6, 2025 | Gilbert Ray Cisneros Jr. | Sell | $1,001 to $15,000 | Dec 15, 2025 | Open card |
| Oct 31, 2025 | Lisa C. McClain | Sell | $1,001 to $15,000 | Nov 21, 2025 | Open card |
| Oct 30, 2025 | Lisa C. McClain | Sell | $1,001 to $15,000 | Nov 21, 2025 | Open card |
| Oct 30, 2025 | Lisa C. McClain | Buy | $1,001 to $15,000 | Nov 21, 2025 | Open card |
| Jun 17, 2025 | Lisa Mcclain | Buy | $1,001 to $15,000 | Aug 13, 2025 | Open card |
| Mar 31, 2025 | Jefferson Shreve | Sell | $15,001 to $50,000 | Apr 11, 2025 | Open card |
| Mar 5, 2025 | April Mcclain Delaney | Buy | $1,001 to $15,000 | Apr 2, 2025 | Open card |
| Feb 24, 2025 | Jefferson Shreve | Sell | $50,001 to $100,000 | Mar 9, 2025 | Open card |
| Oct 31, 2024 | Josh Gottheimer | Sell | $1,001 to $15,000 | Nov 6, 2024 | Open card |
| Jun 21, 2024 | Josh Gottheimer | Sell | $1,001 to $15,000 | Jul 9, 2024 | Open card |
| May 16, 2024 | Michael T. McCaul | Sell | Receipt pending ingestion | Jun 13, 2024 | Open card |
| May 13, 2024 | Michael T. McCaul | Sell | Receipt pending ingestion | Jun 13, 2024 | Open card |
| Apr 24, 2024 | Michael T. McCaul | Sell | Receipt pending ingestion | May 11, 2024 | Open card |
| Nov 1, 2023 | Michael T. McCaul | Buy | Receipt pending ingestion | Dec 9, 2023 | Open card |
| Mar 16, 2023 | Michael T. McCaul | Buy | Receipt pending ingestion | Apr 19, 2023 | Open card |
| Dec 28, 2022 | Michael T. McCaul | Buy | Receipt pending ingestion | Jan 19, 2023 | Open card |
| Jun 21, 2022 | Josh Gottheimer | Buy | $1,001 to $15,000 | Jul 22, 2022 | Open card |
| May 23, 2022 | Ro Khanna | Sell | Receipt pending ingestion | Jun 10, 2022 | Open card |
| May 5, 2022 | Ro Khanna | Buy | Receipt pending ingestion | Jun 10, 2022 | Open card |
| Feb 11, 2020 | Ro Khanna | Sell | Receipt pending ingestion | Mar 9, 2020 | Open card |
| Jan 8, 2020 | Ro Khanna | Buy | Receipt pending ingestion | Feb 10, 2020 | Open card |
| May 18, 2016 | Richard L. Hanna | Exchange | $50,001 to $100,000 | Jun 30, 2016 | Open card |
| Feb 1, 2016 | Thomas Macarthur | Sell | $15,001 to $50,000 | Mar 3, 2016 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 15 of 25 filed rows include disclosed amount ranges (60%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.